Status:
COMPLETED
Rotavirus Vaccine in Premature Babies
Lead Sponsor:
University of Oxford
Conditions:
Gastroenteritis
Eligibility:
All Genders
8-15 years
Brief Summary
This study will establish the duration of excretion of rotavirus vaccine in stool following vaccination of premature babies hospitalised in a neonatal unit at the time of vaccination.
Detailed Description
Rotavirus is the commonest cause of severe gastroenteritis in young children, and premature babies are at high risk of serious disease. The RV1 rotavirus vaccine is an altered form of the virus and is...
Eligibility Criteria
Inclusion
- Participant's parent is willing and able to give informed consent for participation in the study.
- Current inpatient in the neonatal unit and expected to remain an inpatient for at least 14 days following immunisation with rotavirus vaccine.
- Due to receive rotavirus vaccination during their admission.
- Born at less than 37 completed weeks gestation (i.e. up to and including 36 weeks and 6 days)
Exclusion
- • Parent is listed on the study delegation log.
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02252029
Start Date
December 1 2014
End Date
September 1 2016
Last Update
May 9 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Paediatrics, University of Oxford
Oxford, Oxfordshire, United Kingdom, OX3 9DU
2
Oxford University Hospitals NHS Trust
Oxford, United Kingdom